23 results on '"Goldberg G"'
Search Results
2. Oxaliplatin plus continuous infusion topotecan: An ongoing phase II study for recurrent ovarian cancer—A New York Cancer Consortium study (#N01-CM62204).
3. Long-term survival and long-lived immune memory in patients with metastatic melanoma vaccinated with melanoma-antigen loaded dendritic cells.
4. Rising CA-125 levels within the normal range in patients with uterine papillary serous cancer.
5. Evaluation of overexpression of HER2/neu in primary uterine, ovarian, and peritoneal papillary serous carcinoma.
6. Effect of oral aprepitant in management of delayed chemotherapy-induced nausea and vomiting (DCINV) after high-dose chemotherapy (HDC) and hematopoietic stem cell transplant (HCT)
7. Oxaliplatin plus continuous infusion topotecan: First stage of an ongoing phase II study for recurrent ovarian cancer: A New York Cancer Consortium study (#N01-CM62204)
8. In vitro comparative efficacy of ON01910.Na and cisplatin with radiation on cervical carcinoma cells
9. Phase I clinical trial of ixabepilone and pegylated liposomal doxorubicin in patients with advanced breast or ovarian cancers: New York Cancer Consortium Trial P7229
10. A phase 1 study of oral navelbine in patients with advanced solid tumors
11. Compliance and persistency with imatinib
12. The impact of non-compliance with imatinib (IM) therapy on health care costs
13. Pharmacokinetic (pk) and safety study of irinotecan (Ir) and capecitabine (Cp) administered on a weekly schedule
14. Effect of ketoconazole on the pharmacokinetics and pharmacodynamics of ixabepilone
15. Do specialized oncology units improve the detection and management of pain?
16. Modulation of irinotecan (Ir) efficacy with capecitabine (Cp): Albert Einstein and Montefiore Cancer Center experience
17. The response of five primary ovarian cancer cell lines to taxol compared to the results of extreme drug resistance (EDR) assays
18. A phase I clinical trial with weekly irinotecan (IRI) and capecitabine (CAP) in patients with advanced gastrointestinal and other solid malignancies
19. A phase I clinical trial with weekly irinotecan (IRI) and capecitabine (CAP) in patients with advanced gastrointestinal and other solid malignancies
20. Clinical impact of chemotherapy-induced thrombocytopenia in patients with gynecologic cancer.
21. Pilot trial of cisplatin, radiation, and WR2721 in carcinoma of the uterine cervix: a New York Gynecologic Oncology Group study.
22. Management of hypocalcemic effects of WR2721 administered on a daily times five schedule with cisplatin and radiation therapy. The New York Gynecologic Oncology Group.
23. Phase II study and long-term follow-up of patients treated with taxol for advanced ovarian adenocarcinoma.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.